Lindsey Rolfe insider trades

Open-market stock purchases and sales by Lindsey Rolfe, Director at Cero Therapeutics Holdings, Inc, from SEC Form 4 filings since Oct 5, 2015.

Recent trades

DateStockTradeValue
Jan 7, 2026CERO Cero Therapeutics Holdings, IncBought (not open market)—

Companies traded

  • CERO Cero Therapeutics Holdings, Inc: other filings, last Jan 7, 2026
  • BCEL Atreca, Inc: other filings, last Jun 13, 2023
  • CLVS Clovis Oncology, Inc: 64 sales, last Nov 2, 2022

Get free alerts when Lindsey Rolfe files a new trade →